Mechanisms of multidrug resistance in human tumor cells. The roles of P-glycoprotein, DNA topoisomerase II, and others factors, Cancer Treat Rev, vol.17, pp.11-20, 1990. ,
Apoptosis and the dilemma of cancer chemotherapy, Blood, vol.89, pp.1845-1853, 1997. ,
A family of drug transporters: the multidrug resistance-associated proteins, J Natl Cancer Inst, vol.92, issue.16, pp.1295-1302, 2000. ,
Multidrug resistance in cancer: Role of ATP-dependant transporters, Nature, vol.2, pp.48-58, 2002. ,
Biochemistry of multidrug resistance mediated by the multidrug transporter, Ann Rev Biochem, vol.62, pp.385-427, 1993. ,
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants, Biochim Biophys Acta, vol.455, pp.152-162, 1976. ,
The MDR1 gene, reponsible for multidrug resistance, codes for P-glycoprotein, Biochim Biophys Res Comm, vol.141, issue.3, pp.956-962, 1986. ,
Internal duplication and homology with bacterial transport proteins in the MDR1 (P-glycoprotein) gene from multidrug-resistant human cells, Cell, vol.47, pp.381-389, 1986. ,
Overexpression of a transporter gene in a multidrug-resistance human lung cancer line, Science, vol.258, pp.1650-1654, 1992. ,
Overexpression of multidrug resistanceassociated protein (MRP) increases resistance to natural drugs, Cancer Res, vol.54, pp.357-361, 1994. ,
The multidrug resistance protein family, Biochim Biophys Acta, vol.1461, pp.347-357, 1999. ,
Breast cancer resistance protein and Pglycoprotein in 149 adult acute myeloid leukemias, Clin Cancer Res, vol.10, pp.7896-7902, 2004. ,
From MDR to MXR; new understanding of multidrug resistance systems, their properties and clinical signifiance, Cell Mol Life Sci, vol.58, pp.931-959, 2001. ,
An inventory of the human ABC proteins, Biochim Biophys Acta, vol.1461, pp.237-262, 1999. ,
The medicinal chemistry of multi-drug resistance (MDR) reversing drugs, Il Farmaco, vol.57, pp.385-415, 2002. ,
Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil, Cancer Res, vol.41, 1967. ,
Reversal of MDR by verapamil analogues, Hematology, vol.9, issue.1, pp.47-56, 2004. ,
Structure-activity relationship of verapamil analogs and reversal of multidrug resistance, Biochem Pharmacol, vol.50, issue.8, pp.1245-1255, 1995. ,
Novel multidrug resistance reversal agents, J Med Chem, vol.42, pp.2145-2161, 1999. ,
A: Reversal of multidrug resistance by verapamil analogues, Biochem Pharmacol, vol.50, issue.4, pp.451-457, 1995. ,
Design, synthesis and in vitro activity of catamphilic reverters of multidrug resistance: Discovery of a selective, highly efficacious chemosensitizer with potency in the nanomolar range, J Med Chem, vol.42, pp.1687-1697, 1999. ,
Structure-activity relationships 2-(3,4-dimethoxyphenyl)-5-(9-fluorenylamino)-2-(methylethyl) pentanenitrile and its N-methyl derivative, Bioorg Med Chem, vol.9, pp.2673-2682, 2001. ,
Multidrug reverting activity toward leukemia cells in a group of new verapamil analogues with low cardiovascular activity, Leukemia Res, vol.30, pp.1-8, 2006. ,
, Synthèse et évaluation biologique de nouveaux inhibiteurs de Pgp et MRP-1, 2003.
Halogenated chalcones with high affinity binding to P-glycoprotein: potential modulators of multidrug resistance, J Med Chem, vol.41, pp.4161-4164, 1998. ,
URL : https://hal.archives-ouvertes.fr/hal-00313626
Enzymecatalyzed improved resolution of (RS)-4-cyano-4-(3,4-dimethoxyphenyl)-4-isopropyl-1-butanol, Tet Assym, vol.10, pp.3759-3767, 1999. ,
Phasetransfer-catalyzed N-alkylation of N-substitued formamidesalternative procedure for the Ritter reaction, Synth Comm, vol.79, pp.549-552, 1979. ,
Novelties of solid-liquid phase transfer catalysed synthesis of ?-isopropyl-p-chlorophenyl acetonitrile from p-chlorophenyl acetonitrile, Org Proc Res Dev, vol.7, issue.4, pp.588-598, 2003. ,
Iodination of phenols using chloramine T and sodium iodide, Tet Lett, vol.26, issue.17, pp.2043-2046, 1985. ,
Different kinetics of the regulation of respiration in permeabilized cardiomyocytes and in HL-1 cardiac cells. Importance of cell structure/organization for respiration regulation, Biochim Biophys Acta, vol.1757, pp.1597-1606, 2006. ,
Halogen bondings-a novel interaction for rational drug design, J Med Chem, vol.52, pp.2854-2862, 2009. ,